中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
热门
Functional Cooperation of RKTG with p53 in Tumorigenesis and Epithelial-Mesenchymal Transition

文献类型:期刊论文

作者Jiang, Yuhui; Xie, Xiaoduo; Li, Zhigang; Wang, Zheng; Zhang, Yixuan; Ling, Zhiqiang; Pan, Yi(潘怡); Wang, ZhenZhen(王甄真); Chen, Yan(陈雁)
刊名CANCER RESEARCH
出版日期2011
卷号71期号:8页码:2959-2968
英文摘要Raf kinase trapping to Golgi (RKTG) is a potential tumor suppressor gene due to its negative roles in regulating Ras/Raf/MEK/ERK (extracellular signal-regulated kinase) pathway and GPCR (G protein-coupled receptor) G beta gamma subunit signaling. Interestingly, RKTG-deficient mice are free of tumors, although they are prone to form skin cancer on carcinogen administration. On the other hand, p53 is a well-characterized tumor suppressor gene and p53 heterozygous mice develop sarcoma and other tumors starting from 12 months of age. In RKTG-null mouse embryonic fibroblasts, lypophosphatidic acid (LPA), but not EGF (epidermal growth factor), could stimulate hyperphosphorylation of AKT and GSK3 beta, accompanied by increases in phosphorylation of p53 at Ser15 and accumulation of p53, as well as its target genes p21 and p16. Spontaneous skin cancer-like tumors were detected in about 25% of RKTG nullizygous and p53 heterozygous mice within 7 months of age. Hyperplasia and epithelial-mesenchymal transition (EMT) were observed in the tumor-overlying epidermis, in which LOH of p53 occurred and EMT features emerged. In p53-mutated A431 epithelial carcinoma cells, knockdown of RKTG led to enhancement of LPA-stimulated AKT and GSK3 beta phosphorylation, together with increased accumulation of beta-catenin and appearance of EMT features that were antagonized by p53 overexpression. In HepG2 epithelial cells, LPA-stimulated AKT phosphorylation and EMT features reached maximum when both RKTG and p53 were simultaneously silenced. In summary, these results not only indicate that RKTG has an in vivo tumor suppressor function to cooperate with p53 in tumorigenesis but also suggest that p53 has an EMT checkpoint function and the loss of this function can combine with loss of RKTG to drive EMT and tumor progression. Cancer Res; 71(8); 2959-68. (C)2011 AACR.
类目[WOS]Oncology
关键词[WOS]BETA-CATENIN ; CELL CARCINOMA ; CANCER-CELLS ; E-CADHERIN ; DOWN-REGULATION ; AKT ; ACTIVATION ; PHOSPHORYLATION ; MICE ; INACTIVATION
收录类别SCI
语种英语
WOS记录号WOS:000289507800016
版本出版稿
源URL[http://202.127.25.144/handle/331004/77]  
专题中国科学院上海生命科学研究院营养科学研究所_信号转导与营养相关疾病研究组
推荐引用方式
GB/T 7714
Jiang, Yuhui,Xie, Xiaoduo,Li, Zhigang,et al. Functional Cooperation of RKTG with p53 in Tumorigenesis and Epithelial-Mesenchymal Transition[J]. CANCER RESEARCH,2011,71(8):2959-2968.
APA Jiang, Yuhui.,Xie, Xiaoduo.,Li, Zhigang.,Wang, Zheng.,Zhang, Yixuan.,...&Chen, Yan.(2011).Functional Cooperation of RKTG with p53 in Tumorigenesis and Epithelial-Mesenchymal Transition.CANCER RESEARCH,71(8),2959-2968.
MLA Jiang, Yuhui,et al."Functional Cooperation of RKTG with p53 in Tumorigenesis and Epithelial-Mesenchymal Transition".CANCER RESEARCH 71.8(2011):2959-2968.

入库方式: OAI收割

来源:上海营养与健康研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。